Navigation Links
Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease
Date:2/4/2008

ANN ARBOR, Mich., Feb. 4 /PRNewswire/ -- Pfizer's loss of some top talent, including Lipitor pioneer Dr. Bob Sliskovic, is the gain of two Michigan companies teaming to help speed research to fight bone diseases such as multiple myeloma, metastatic bone disease, rheumatoid arthritis and osteoporosis.

Velcura Therapeutics President and CEO Michael W. Long, PhD, announced his biotechnology company will work with Dr. Sliskovic and International Discovery Sourcing Consultants, LLC (IDSC), on the design and sourcing of medicinal chemistry data for its second generation and new bone therapy molecules. "IDSC brings added drug discovery leadership, experienced vendors and project managers as we begin our clinical trial this year for VEL-0230, a new drug that stimulates bone formation and inhibits bone loss," said Long.

"We offer in-depth support for scientific programs and also welcome a long-term partnership with firms like Velcura that are outsourcing," said IDSC President and CEO Mark Creswell. "The pharmaceutical industry experts joining us from Pfizer have 17-30 years of experience; we have chaired multiple projects that moved drug candidates into the clinic," he added. "Bob Sliskovic, for example, was responsible for the development of some 30 clinical candidates, including Lipitor."

Dr. Sliskovic, who was featured in the Dec. 11, 2007 Wall Street Journal, now dreams of being involved in another blockbuster like Lipitor. The work that he is doing now with IDSC could help Velcura to develop a treatment to help millions of individuals suffering from bone diseases like Osteoporosis, which is second to heart disease as a world health problem.

About Velcura Therapeutics(R), Inc.

Velcura Therapeutics Inc. is an early-stage biotechnology company headquartered in Ann Arbor, Michigan. Velcura's research focus is to better understand human bone disease and to discover novel therapeutics that restore bone health. Velcura develops highly
'/>"/>

SOURCE Velcura Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
2. Velcura Therapeutics, Inc. Appoints Industry Executive to Lead Regulatory Affairs
3. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
4. Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimers Treatments
5. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
6. Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders
7. Cell Therapeutics, Inc. (CTI) Prices $1.27 million (euros 856.000) Offering of Common Stock through Societe Generale
8. Cell Therapeutics, Inc. Announces Authorization to Publish Italian Listing Prospectus
9. Cell Therapeutics, Inc. (CTI) Hosts Conference Call to Discuss Update on Zevalin(R) Acquisition, CMS Reimbursement, and PIX301 Timeline
10. Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
11. Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in O... consistent growth during the U.S. recession. Howe...uble, and health systems are coming closer to havi...ust administrators. , (Vo...ontinued growing in October despite the shedding o...
(Date:11/24/2009)...AI, Nov. 24 /PRNewswire-Asia/ -- NOD Pharmaceutica...fice (PTO) has allowed the patent application for,... , NOD technology is a highly efficient a...io-adhesive nano-particles to enable oral delivery...D technology is a platform technology,that can be ...
(Date:11/24/2009)...GHAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai Biolax...nistration (SFDA) has approved the,investigational...roject,(Nodlin), an innovative insulin formulation...xy to initiate its first phase I clinical study. ,... high blood glucose and poor,metabolism. The compl...
(Date:11/24/2009)... The FBI recently approved the Promega PowerPlex 1...in or generating DNA records for the National DNA ...WI USA (PRWEB) -- The FBI recently approved the Pr...oratories participating in, or generating DNA reco...S currently contains more than seven million profi...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...arch 27 Local biotechnology leader,MedImmune anno... Yiwei Li,has received the distinguished "MedImmun...er ScienceMONTGOMERY project. The company sponsore...enceMONTGOMERY, for the,fourth-consecutive year an...work of a current Montgomery County high school ju...
...rch 27 As hospital leaders prepare,for the public... Center for,Medicare & Medicaid Services ( http://...t expert Mary P. Malone is offering insights about...and families. Data from the H-CAHPS,( http://www.c...rnment,s,Hospital Compare web site ( http://www.ho...
...ter Patent Granted and Enforceable in 24 European ...itors Precluded from Immediate Commercialization o...cts, LAVAL, QC, March 27 /PRNewswire-FirstCall/ -...ne") (NASDAQ.NEPT - TSX.V.NTB) announces that the,...007 Neptune,s composition,of matter patent entitle...
Other Biology Technology:Seneca Valley High School Student Receives Science Award From MedImmune 2Seneca Valley High School Student Receives Science Award From MedImmune 3Patient Experience Expert to Present 'The Power of Wow!' in Health Care Service Delivery 2Neptune Technologies patent granted for novel phospholipids in multiple diseases and pharmaceutical applications 2Neptune Technologies patent granted for novel phospholipids in multiple diseases and pharmaceutical applications 3
(Date:11/26/2009)... Prized for their impressive antlers, red deer ha...ons. But a deer,s antlers are much more than decor...gether when duelling. John Currey, from The Univer...ical properties of bone for over half a century an...es of antler through a long-standing collaboration...
(Date:11/26/2009)... MRSA (methicillin-resistant Staphylococcus Aure...annihilation as low-temperature plasma prototype d...asy and unfailing bactericidal cocktails. , Two ...icient disinfection of healthy skin (e.g. hands an...ria can pose a lethal threat; and another to shoot...
(Date:11/25/2009)..., Dr. Sarit Larisch, Head of the Cell Death Rese...tment of Biology, has been awarded the prestigious...esearch exploring the cause of brain cell damage i... each year to scientists in support of innovation ...and officially conferred earlier this month at an ...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2ESC to give talks on diabetes in 3 cities in China 61820 1ESC to give talks on diabetes in 3 cities in China 61820 2Nu U Medspa to Offer Dysport Zerona SmartLipo at HealthySkinPortal com 61817 1Nu U Medspa to Offer Dysport Zerona SmartLipo at HealthySkinPortal com 61817 2Nu U Medspa to Offer Dysport Zerona SmartLipo at HealthySkinPortal com 61817 3General Dynamics Employee Joe Nichols M D Honored with Healthcare System Taskforce Award of Merit 61812 1General Dynamics Employee Joe Nichols M D Honored with Healthcare System Taskforce Award of Merit 61812 2
...ould be much easier for them to penetrate healthy ...ases. Scientists at the Pharmacology Institute of ...reviously unknown cell signal factor SCAI (suppres...ovement and spread of tumor cells in laboratory te...the cancer cells moved much more effectively in wh...
...emperatures and limited water availability are maj...o agriculture around the world. Ben-Gurion Univer...of a research collaboration with Bayer BioScience ...hent, Belgium, to develop solutions to these chall...d breakthrough results from Dr. Simon Barak,s labo...
... conducted in the Midwestern United States examine...ivated and uncultivated soils, vastly advancing th...l aggregation is an important soil attribute that ...oil, and is one of the essential processes that de... U.S. Midwest, upland soils are often under water ...
Other Biology News:How tumor cells move 2Ben-Gurion University of the Negev signs collaborative contract with Bayer CropScience 2Impact of floods on soils 2
Goat Anti-Human PLUNC Polyclonal Antibody, Biotin Conjugated from R&D Systems
Rabbit Anti-Human HCARG Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Mouse Anti-Human RXR beta / NR2B2 Monoclonal Antibody, Unconjugated, Clone H7341 from R&D Systems
Mouse Anti-Human ULBP-3 Monoclonal Antibody, Unconjugated, Clone 166514 from R&D Systems
Biology Products: